Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31147870 | 1.00 | NPC1 (0.61) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL7667060 | 0.82 | PNMT (0.56) | NPC1RAB9ACYP3A4CYP2D6CYP2C9 | |
| SCHEMBL6072254 | 0.80 | CHRM2 (0.72) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL6869146 | 0.78 | IDO1 (0.58) | NPC1RAB9ACHRM2MEN1KMT2A | |
| Iodide SCHEMBL9478324 | 0.78 | CHRM2 (0.69) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL11957887 | 0.77 | CHRM2 (0.62) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL7347293 | 0.77 | PTGS2 (0.62) | KMT2ACYP3A4CYP2C9 | |
| SCHEMBL15587772 | 0.76 | NPC1 (0.55) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL6068451 | 0.76 | PNMT (0.56) | NPC1RAB9ACHRM2MEN1KMT2A | |
| SCHEMBL4573865 | 0.76 | RAB9A (0.55) | NPC1RAB9ACHRM2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110963976-A | Method and device for producing clomazone by electrodialysis method | 潍坊先达化工有限公司 | 2020-04-07 | — | — | CN | claimed |
| US-11649219-B2 | Process for preparing a clomazone, novel form and use of the same | ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (HK) | 2023-05-16 | — | — | US | disclosed |
| CN-113024479-B | Preparation method of clomazone | 江苏长青农化股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-113024479-A | Preparation method of clomazone | 江苏长青农化股份有限公司 | 2021-06-25 | — | — | CN | disclosed |
| EP-3817554-A1 | SYNERGISTICALLY EFFECTIVE HERBICIDE COMPOSITION COMPRISING METOBROMURON AND CLOMAZONE | Belchim Crop Protection NV (BE) | 2021-05-12 | — | — | EP | disclosed |
| CN-110963976-A | Method and device for producing clomazone by electrodialysis method | 潍坊先达化工有限公司 | 2020-04-07 | — | — | CN | disclosed |
| CN-110963976-A | Method and device for producing clomazone by electrodialysis method | 潍坊先达化工有限公司 | 2020-04-07 | — | — | CN | disclosed |
| WO-2020007810-A1 | SYNERGISTICALLY EFFECTIVE HERBICIDE COMPOSITION COMPRISING METOBROMURON AND CLOMAZONE | BELCHIM CROP PROTECTION NV (BE) | 2020-01-09 | — | — | WO | disclosed |
| US-10316004-B2 | Process for preparing clomazone, novel form and use of the same | ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (HK) | 2019-06-11 | — | — | US | disclosed |
| US-4405357-A | Herbicidal 3-isoxazolidinones and hydroxamic acids | FMC CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4302238-A | Herbicidal isoxazolidine-3,5-diones | FMC CORPORATION (US) | 1981-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649219-B2 | Process for preparing a clomazone, novel form and use of the same | DNMT3A, CYP2C9, CYP2C19 | NPC1 3087/4885RAB9A 2483/4885CHRM2 518/4885 |
| US-10316004-B2 | Process for preparing clomazone, novel form and use of the same | DNMT3A, CYP2C9, CYP2C19 | NPC1 3322/4885RAB9A 2356/4885CHRM2 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.